Literature DB >> 26487334

Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival.

Alexander Wilhelm, Sascha A Müller, Thomas Steffen, Bruno M Schmied, Ulrich Beutner, Rene Warschkow.   

Abstract

PURPOSE: To assess the influence of regional lymph node (RLN) retrieval on stage migration of adenocarcinoma of the small intestine and survival. PATIENTS AND METHODS: From the Surveillance, Epidemiology, and End Results database,1090 patients with nonmetastatic small bowel adenocarcinoma were identified in between 2004 and 2011. The impact of the number of RLNs removed on histopathological staging and oncological outcome was assessed utilizing Cox proportional hazard regression models with and without risk-adjustment, propensity score methods, and joinpoint regression analysis.
RESULTS: The rate of node-positive cancer increased steadily with the number of retrieved RLNs up to 9 RLNs, which suggests that a minimum of 9 (95 % CI 5.5–10.5) retrieved RLNs are needed for the detection of node-positive disease (P < 0.001). From 657 of 1090 patients (60.3 %), 9 or more RLNs were retrieved. While in 2004 only in 46.0 % of all cases 9+ RLNs were retrieved, this rate increased to 69.3 % in 2011 (P < 0.001). The multivariable analysis demonstrated that the retrieval of 9+ RLNs was associated with better overall (hazard ratio of death [HR] = 0.67, 95 % CI 0.55–0.82, P < 0.001) and cancer-specific survival (HR = 0.77, 95 % CI 0.61–0.96, P = 0.022). This finding was confirmed by a propensity score-adjusted analysis, which indicated increased overall (HR = 0.67, 95 % CI 0.50–0.89, P < 0.001) and cancer-specific survival (HR = 0.67, 95 % CI 0.49–0.92, P = 0.013) in patients with the retrieval of 9+ RLNs.
CONCLUSION: To our knowledge, this is the first population-based propensity score-adjusted investigation in small bowel adenocarcinoma. A sufficient number of RLNs should be retrieved to achieve an optimal oncological outcome

Entities:  

Mesh:

Year:  2016        PMID: 26487334     DOI: 10.1007/s11605-015-2994-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

Review 1.  Invited commentary: propensity scores.

Authors:  M M Joffe; P R Rosenbaum
Journal:  Am J Epidemiol       Date:  1999-08-15       Impact factor: 4.897

2.  Estimating regression models with unknown break-points.

Authors:  Vito M R Muggeo
Journal:  Stat Med       Date:  2003-10-15       Impact factor: 2.373

3.  New aspects of prognostic factors in adenocarcinomas of the small bowel.

Authors:  B L Brücher; H J Stein; J D Roder; R Busch; U Fink; M Werner; J R Siewert
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

Review 4.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

5.  Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.

Authors:  Bouthaina S Dabaja; Dima Suki; Barbara Pro; Mark Bonnen; Jaffer Ajani
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

6.  Incidence of histologic types of cancer of the small intestine.

Authors:  N S Weiss; C P Yang
Journal:  J Natl Cancer Inst       Date:  1987-04       Impact factor: 13.506

7.  Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).

Authors:  Phyllis A Wingo; Patricia M Jamison; Robert A Hiatt; Hannah K Weir; Paul M Gargiullo; Mary Hutton; Nancy C Lee; H Irene Hall
Journal:  Cancer Causes Control       Date:  2003-03       Impact factor: 2.506

8.  Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis.

Authors:  Ting-Jung Wu; Chun-Nan Yeh; Tzu-Chieh Chao; Yi-Yin Jan; Miin-Fu Chen
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

Review 9.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

10.  Lymph node evaluation for colon cancer in an era of quality guidelines: who improves?

Authors:  Helen M Parsons; James W Begun; Karen M Kuntz; Todd M Tuttle; Patricia M McGovern; Beth A Virnig
Journal:  J Oncol Pract       Date:  2013-03-19       Impact factor: 3.840

View more
  5 in total

1.  Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database.

Authors:  Yu Jin Lim; Kyubo Kim
Journal:  Int J Clin Oncol       Date:  2017-12-19       Impact factor: 3.402

2.  Influence of marital status on small intestinal adenocarcinoma survival: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Zhihui Chen; Ji Cui; Weigang Dai; Hong Yang; Yulong He; Xinming Song
Journal:  Cancer Manag Res       Date:  2018-11-14       Impact factor: 3.989

Review 3.  Localized Small Bowel Adenocarcinoma Management: Evidence Summary.

Authors:  Anthony Turpin; Mehdi El Amrani; Aziz Zaanan
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

4.  Surgical Resection of Metastatic Malignant Small Bowel Obstruction.

Authors:  Nickolas G Kessler; Michael Franz
Journal:  Cureus       Date:  2022-07-28

5.  Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.

Authors:  Alessandro Vanoli; Federica Grillo; Camilla Guerini; Giuseppe Neri; Giovanni Arpa; Catherine Klersy; Gabriella Nesi; Paolo Giuffrida; Gianluca Sampietro; Sandro Ardizzone; Paolo Fociani; Roberto Fiocca; Giovanni Latella; Fausto Sessa; Antonietta D'Errico; Deborah Malvi; Claudia Mescoli; Massimo Rugge; Stefano Ferrero; Gilberto Poggioli; Fernando Rizzello; Maria C Macciomei; Donatella Santini; Umberto Volta; Roberto De Giorgio; Giacomo Caio; Antonio Calabrò; Carolina Ciacci; Maria D'Armiento; Aroldo Rizzo; Gaspare Solina; Michele Martino; Francesco Tonelli; Vincenzo Villanacci; Renato Cannizzaro; Vincenzo Canzonieri; Ada Maria Florena; Livia Biancone; Giovanni Monteleone; Roberto Caronna; Antonio Ciardi; Luca Elli; Flavio Caprioli; Maurizio Vecchi; Renata D'Incà; Fabiana Zingone; Anna D'Odorico; Marco Vincenzo Lenti; Barbara Oreggia; Luca Reggiani Bonetti; Antonino Giulio Giannone; Augusto Orlandi; Valeria Barresi; Rachele Ciccocioppo; Giuseppe Amodeo; Elena Biletta; Ombretta Luinetti; Paolo Pedrazzoli; Andrea Pietrabissa; Gino Roberto Corazza; Enrico Solcia; Marco Paulli; Antonio Di Sabatino
Journal:  Ann Surg Oncol       Date:  2020-08-05       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.